Effect on gut microbiome emerges as another benefit of statin therapy
Randomized controlled study undercuts unsubstantiated ‘heart health’ claims
Increased risk is partly mediated by microbiota-derived metabolites of L-carnitine, choline
Medicare database analysis finds reduced risk of death, heart failure, myocardial infarction and stroke
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Targeted mRNA blocking could be first effective approach specific to this cardiovascular risk factor
Provocative findings from a hypothesis-generating study
New review identifies the limited guidance that can be offered
New revision aligns with other major guidelines’ recommendations
Updated guidance on identification and strategies for management
Web-based self-selection tool aims to achieve long-sought nonprescription statin access
Advertisement
Advertisement